A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
Saved in:
| Title: | A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus. |
|---|---|
| Authors: | Jenks JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Amin S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Sponholtz MR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Kumar A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Venkatayogi S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Tu JJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Karthigeyan K; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America., Valencia SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Connors M; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America., Harnois MJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Rochat E; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America., Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America., Permar SR; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2023 Jan 20; Vol. 19 (1), pp. e1011107. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1011107 |
